ADALIMUMAB , INFLIXIMAB
Approved small_molecule active
Quick answer
ADALIMUMAB , INFLIXIMAB for Crohn's disease Ulcerative colitis is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Crohn's disease Ulcerative colitis
- Phase
- Approved
- Modality
- small_molecule
- Status
- active